المؤلفون: Natalia Riva (12001316), Manuel Molina (12001319), Berta L. Cornaló (12001322), María V. Salvador (12001325), Andrea Savransky (12001328), Silvia Tenembaum (6493442), María M. Katsicas (12001331), Marta Monteverde (12001334), Paulo Cáceres Guido (12001337), Marcela Rousseau (12001340), Raquel Staciuk (12001343), Agustín González Correas (12001346), Pedro Zubizarreta (12001349), Oscar Imventarza (12001352), Eduardo Lagomarsino (12001355), Eduardo Spitzer (12001358), Marcelo Tinelli (12001361), Paula Schaiquevich (2558245)

مصطلحات موضوعية: Pharmacology, Basic Pharmacology, Clinical Pharmacology and Therapeutics, Clinical Pharmacy and Pharmacy Practice, Pharmaceutical Sciences, Pharmacogenomics, Toxicology (incl. Clinical Toxicology), Pharmacology and Pharmaceutical Sciences not elsewhere classified, Rituximab, Biosimilar Pharmaceuticals, Monoclonal Antibody, Pediatric, Adverse Drug Reactions, Hypersensitivity, Risk Factors

Relation: https://figshare.com/articles/dataset/DataSheet1_Intensive_Safety_Monitoring_of_Rituximab_Biosimilar_Novex_and_the_Innovator_in_Pediatric_Patients_With_Complex_Diseases_doc/19069193

الاتاحة: https://doi.org/10.3389/fphar.2021.785770.s001